Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Stock Report

| More

Dr. Reddy's launches Condition Management programme 'DailyBloom™ IBS'

Posted On: 2024-04-21 15:55:06 (Time Zone: IST)

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as "Dr. Reddy's"), a global pharmaceutical company, today announced the roll-out of its condition management programme DailyBloomTM IBS, India's first integrated care plan for Irritable Bowel Syndrome (IBS). The programme is based on extensive research and is enabled by a mobile application developed in-house. DailyBloom™ IBS focuses on a comprehensive care plan that includes diet management, psychological and physical wellness support for patients with IBS. Dr. Reddy's has launched the programme on 'World IBS Day', a day that aims to increase awareness of the IBS condition, discuss misconceptions, challenges and even stigma attached to it.

Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder characterised by abdominal pain, bloating and altered bowel habits1. Studies show that IBS leads to significant morbidity, work absenteeism, loss of productivity, economic burden to the society, and impacts the quality of life of patients2. Around 7% of the Indian population suffers from IBS. Psychological and somatoform comorbidities are often seen in IBS patients. Being a chronic condition, IBS can be managed more effectively by using an integrated care approach involving education, lifestyle changes, personalised nutrition and wellness, along with standard of care medical management.

Dr. Reddy's DailyBloom™ IBS is a 14-week care plan that comes with a personalised approach to ensure that each patient's experience is tailored to their specific needs. The journey of a patient on the care plan begins with the DailyBloom Gut Health Index, an initial assessment that captures the frequency of symptoms and impact on their quality of life. Following this assessment, patients engage in a goal-setting session, allowing for further personalisation of their care pathway. This crucial step ensures that each plan aligns with the individual's health goals and lifestyle preferences, making the management of IBS more effective and aligned with the patient's life. In the 14-week journey, patients receive 16+ consultations from a team of certified nutritionists, psychologists and care managers complemented by unlimited chat support from the care team. The program also provides users with access to over 500 gutfriendly recipes based on Indian cuisine to help them manage their condition successfully.

DailyBloom™ IBS care plan aims to bridge the gap in the effective management of IBS by providing patients in India with seamless access to integrated care conveniently at their fingertips. DailyBloom™ IBS was built in consultation with a team of multi-disciplinary experts, patients and gastroenterologists and based on rigorous research over a period of 12 months. The exhaustive research process included 9,600+ minutes of doctor and patient immersions, 3,000+ observations, and understanding of 300+ pain points linked to IBS. Preliminary user experience has generated highly positive response to DailyBloom™ IBS.

M.V. Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets), Dr. Reddy's, said: "Apart from growing our core business, our strategy for India is based on the three innovative and synergistic pillars of access to novel molecules, consumer health, and digital therapeutics. Our aim is to meet unmet needs of patients and enhance standard of care where possible. In the digital therapeutics segment, as with the drug-free migraine management device Nerivio®, DailyBloom™ IBS also offers a differentiated value proposition to patients. 'DailyBloom™ IBS' has been developed in-house, based on rigorous research and extensive consultation with experts including gastroenterologists. IBS is a chronic condition and its symptoms are often misdiagnosed or neglected4. Our initiative is India's first integrated care plan for IBS. We have drawn on our three-decade old market leadership in the gastrointestinal (GI) segment consisting of trusted and established oral drug brands such as Omez®, Razo™, Econorm®, and Redotil™. We are therefore happy to offer an integrated care approach to this GI condition that aims to enhance standard of care in keeping with our purpose of 'Good Health Can't Wait."

DailyBloom™ IBS is available on Google Play Store and Apple store for download. For more queries, doctors and patients can call the DailyBloom Customer Care helpline number 040-47178120.

Shares of Dr. Reddy's Laboratories Limited was last trading in BSE at Rs. 5942.65 as compared to the previous close of Rs. 5959.10. The total number of shares traded during the day was 26331 in over 4443 trades.

The stock hit an intraday high of Rs. 5970.00 and intraday low of 5881.15. The net turnover during the day was Rs. 155366117.00.

Click here to send ur comments or to

Other Headlines:

Shares of Go Digit General Insurance debuts on the bourses, closes 12% premium

New India Assurance reports 128.4% growth in profit after tax in Q 4FY 24

Astral Limited Launches Comprehensive New Paint Line as Astral Paints

HCLTech's AquaSphere solution wins SAP Pinnacle Award

Saregama Q4 FY24 Total Revenue at Rs.2,810 Mn

Godrej Properties achieves booking value of over INR 2,000 crore through the launch of its project Godrej Jardinia in Noida

L&T Technology Services announces Establishment of Simulation Centre of Excellence for Airbus

Ratnaveer Precision Engineering Ltd reports impressive growth with 23.94% increase in Net Profit, achieving Rs31.04 Crore in FY24

Metro Brands Ltd reports standalone YoY revenue growth of 11%

GRSE records highest ever Profit After Tax and Revenue from Operations during FY 24

Airtel Payments Bank Soars in FY24, Records INR 1,836 Crore of Revenue

Get ready for season 2 of #nofilter by IndiGo

Temp Shield Tiles: Saviour against Scorching Heat

Karur Vysya Bank opens its 840th Branch at Ayodhya today

JK Tyre records highest ever revenues and profits in FY24

HCLTech recognized as a Leader in Gartner® Magic Quadrant™ for Outsourced Digital Workplace Services

BPCL Boosts Aviation Fueling Capabilities with New Hydrant Facilities at Manohar International Airport

Sinclairs Hotels Total Income at ? 6512.59 lakh, up by 13.60%

Moneyboxx Finance reports strong turnaround in profitability in FY24

QubeHealth-Pay launches unique healthcare payment benefits for ION Exchange's 3000 employees

Explore the world with Bata's latest 'Try and Fly' campaign featuring 9 to 9 Collection

Gensol Engineering Ltd. strengthens leadership team with the appointment of Ms. Shilpa Urhekar as CEO, Solar EPC - India

IMFL Maker Tilaknagar Industries Profit After Tax jumps 20.9% in Q4, Revenue Increases to Rs 358.8 Crore

Balu Forge Industries Ltd Expands Forging Capacity

Trident Limited announces interim dividend of INR 0.36 per share for FY 2024-25

SBI General Insurance and Jana Small Finance Bank forge Bancassurance Partnership to increase insurance penetration

Rainbow Children's Medicare Limited recommends final dividend of Rs. 3

Poddar Pigments Limited recommends final dividend of Rs. 4

Ashok Leyland Expands its footprint in Northern India, inaugurates two Dealerships in Faridabad, and one in Greater Noida

Jupiter Wagons Ltd approves preferential issue of warrants to Tatravagonka A.S.

IRIS reports impressive results, enters the Rs 100 cr club

The India Cements Ltd Q4 FY2024 consolidated loss at Rs. 59.05 crores

Rainbow Children’s Medicare Limited consolidated Q4FY24 PAT drops to Rs. 50.97 crores

Poddar Pigments Ltd Q4FY24 profit up at Rs. 8.74 crore

Data Patterns record increased revenue in its Q4 results

Anupam Rasayan India Limited Reports Q4 & FY24 Results

YES BANK Targets India's Elite and Rising Affluent Class for Growth, Launches Premier Banking Services - YES Grandeur

NOD for IDFC First Bank Amalgamation

Modern Engineering and Projects Ltd receives order from Tata Steel Ltd

Waaree Renewable Technologies Ltd receives order worth Rs. 4.89 crore

Tata Sampann launches first of its kind Easy Cook Ragi Atta, a nourishing & convenient cooking choice

Dalmia Bharat boosts capacity with new cement mill of 1.0 MnT at its Ariyalur plant, Tamil Nadu

ESAF Small Finance Bank gets RBI nod for appointment of George Kalaparambil John as Executive Director

IIFL Home Finance becomes India's leading affordable housing finance company with AUM crossing ? 35,000 Crores

Piotex Industries stock makes bumper debut on BSE SME

HomeFirst achieves ?10,000 Crore AUM

RBI approves Mr. Pradeep Natarajan as Whole Time Director of IDFC FIRST Bank Limited

Fusion Micro Finance secures USD 25 million loan from U.S. International Development Finance Corporation

ITI Limited Bags LoIs worth Rs. 37.5 Cr for Solar Street light Systems in Bihar

JK Maxx Paints Launches #SingleBrandSharmaJi Campaign Reinforcing Commitment to Home Beautification

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020